Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

VOE vs XBI: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, VOE returned +22.8% to XBI's +41.2%, and VOE charges 0.05% to XBI's 0.35%.

askIQ about this page

askIQ about VOE and XBI

Net assets: $22.8bn on Sep 30, 2026 for Vanguard Morningstar Mid-Cap Value ETF, and $10.3bn on Oct 27, 2026 for State Street SPDR S&P Biotech ETF.

At a glance
+22.8%
VOE total return, 1 year
+41.2%
XBI total return, 1 year
0.05%
VOE expense ratio
0.35%
XBI expense ratio

Pair scorecard

VOE costs 0.30 points a year less; their one-year returns differ by 18.4 points; VOE is 2.2 times larger.

VOE vs XBI: Differences, Returns & Fees
MeasureVOEXBI
Return
Total return, 1 year+22.8%+41.2%
Drawdown
Below its all-time high8.9%, high on Feb 8, 2021
Benchmark
What it tracksMorningstar US Mid Cap Value IndexBiotech
Cost and size
Expense ratio0.05%0.35%
Net assets, as of Sep 30, 2026$22.8bn$10.4bn
Active share vs the S&P 50098%
Holdings
Holdings in common2%
Top ten holdings, share of the fund14.0%18%

Holdings in common uses holdings dated Sep 30, 2026 and Oct 27, 2026. Method

What they share

2%

By the books each fund has filed, VOE and XBI hold 2% of their money in the same securities at the same weight. Holdings dated Sep 30, 2026 and Oct 27, 2026.

0 half 100%

half

2% in common

Positions both hold · largest shared weight first VOE XBI
Regeneron Pharmaceuticals Inc 0.65% 1.48%
Moderna Inc 0.59% 2.24%
Biogen Inc 0.57% 1.75%
Only in one fund ↓
Only in VOE
Valero Energy Corp 1.90%
Marathon Petroleum Corp 1.89%
Phillips 66 1.73%
Hewlett Packard Enterprise Co 1.37%
Warner Bros Discovery Inc 1.25%
SLB Ltd 1.23%
Target Corp 1.21%
Cummins Inc 1.21%
Only in XBI
TWIST BIOSCIENCE CORP 1.86%
NATERA INC 1.82%
HALOZYME THERAPEUTICS INC 1.75%
UNITED THERAPEUTICS CORP 1.71%
AMGEN INC 1.68%
ABBVIE INC 1.67%
SPYRE THERAPEUTICS INC 1.67%
EXELIXIS INC 1.64%
Check overlap with more funds →

Side by side

VOE Vanguard Morningstar Mid-Cap Value ETF XBI State Street SPDR S&P Biotech ETF
Where it sits Stock ETF Thematic ETF
What it is Tracks an index of Mid-Cap Value Biotech
Total return, 1 year +22.8% +41.2%
Expense ratio 0.05% 0.35%
Already in the S&P 500 96.0% 13.2%
Holdings 169 165
Net assets, VOE as of Sep 30, 2026 and XBI as of Oct 27, 2026 $22.8bn $10.3bn

VOE and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

XBI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
VOE

VOE tracks an index of Mid-Cap Value. Over the year to Oct 28, 2026 it returned +22.8% with distributions reinvested. The prospectus expense ratio is 0.05% a year. By its holdings published by its issuer as of Sep 30, 2026, 96% of the fund by weight is stocks the S&P 500 also holds, across 169 positions, with the top ten at 14.0%.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are VOE and XBI in the same category?
VOE is a stock ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, VOE or XBI?
In the year to Oct 28, 2026, with distributions reinvested, VOE returned +22.8% and XBI +41.2%.
Which is cheaper, VOE or XBI?
VOE is cheaper, by 0.30 percentage points a year. That is about $30 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do VOE and XBI overlap with the S&P 500?
By their latest filed holdings, 96% of VOE and 13% of XBI by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, VOE against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/voe-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.